-+ 0.00%
-+ 0.00%
-+ 0.00%

Annovis Bio Q1 EPS $(0.32) Beats $(0.36) Estimate

Benzinga·05/13/2025 20:47:25
Listen to the news
Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 55.56 percent increase over losses of $(0.72) per share from the same period last year.